NMTC Key Statistics, Chart & Performance
The current stock price of NMTC is 0.8523 USD. In the past month the price increased by 25.12%. In the past year, price decreased by -7.36%.
NMTC Latest News, Press Relases and Analysis
NMTC Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 24.89 | 215.95B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.27 | 199.22B | ||
| BSX | BOSTON SCIENTIFIC CORP | 32.11 | 140.40B | ||
| SYK | STRYKER CORP | 26.44 | 133.15B | ||
| BDX | BECTON DICKINSON AND CO | 13.52 | 55.64B | ||
| IDXX | IDEXX LABORATORIES INC | 53.13 | 53.50B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.2 | 49.52B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 18.04 | 37.73B | ||
| RMD | RESMED INC | 24.73 | 35.73B | ||
| DXCM | DEXCOM INC | 35.77 | 25.95B | ||
| PODD | INSULET CORP | 61.91 | 19.90B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.13 | 17.84B |
Related stock screener links
About NMTC
Company Profile
NeuroOne Medical Technologies Corp. is a medical technology company, which engages in the development and commercialization of thin film electrode technology for continuous electroencephalogram and stereoelectrocencephalography recording, spinal cord stimulation, brain stimulation, and ablation solutions. The company is headquartered in Eden Prairie, Minnesota and currently employs 17 full-time employees. The company went IPO on 2012-11-09. The company is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. The company may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
Company Info
NEUROONE MEDICAL TECHNOLOGIE
7599 Anagram Dr
Eden Prairie MINNESOTA US
Employees: 17
Phone: 19524261383
NEUROONE MEDICAL TECHNOLOGIE / NMTC FAQ
What does NMTC do?
NeuroOne Medical Technologies Corp. is a medical technology company, which engages in the development and commercialization of thin film electrode technology for continuous electroencephalogram and stereoelectrocencephalography recording, spinal cord stimulation, brain stimulation, and ablation solutions. The company is headquartered in Eden Prairie, Minnesota and currently employs 17 full-time employees. The company went IPO on 2012-11-09. The company is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. The company may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
Can you provide the latest stock price for NEUROONE MEDICAL TECHNOLOGIE?
The current stock price of NMTC is 0.8523 USD. The price increased by 12.44% in the last trading session.
Does NMTC stock pay dividends?
NMTC does not pay a dividend.
What is the ChartMill rating of NEUROONE MEDICAL TECHNOLOGIE stock?
NMTC has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the market capitalization of NMTC stock?
NEUROONE MEDICAL TECHNOLOGIE (NMTC) has a market capitalization of 42.62M USD. This makes NMTC a Nano Cap stock.
Can you provide the upcoming earnings date for NEUROONE MEDICAL TECHNOLOGIE?
NEUROONE MEDICAL TECHNOLOGIE (NMTC) will report earnings on 2026-02-10.
What is the ownership structure of NEUROONE MEDICAL TECHNOLOGIE (NMTC)?
You can find the ownership structure of NEUROONE MEDICAL TECHNOLOGIE (NMTC) on the Ownership tab.
NMTC Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to NMTC. When comparing the yearly performance of all stocks, NMTC is a bad performer in the overall market: 73.69% of all stocks are doing better.
NMTC Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to NMTC. NMTC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
NMTC Financial Highlights
Over the last trailing twelve months NMTC reported a non-GAAP Earnings per Share(EPS) of -0.65. The EPS decreased by -3.17% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -48.45% | ||
| ROE | -65.16% | ||
| Debt/Equity | 0.13 |
NMTC Forecast & Estimates
8 analysts have analysed NMTC and the average price target is 2.27 USD. This implies a price increase of 166.28% is expected in the next year compared to the current price of 0.8523.
For the next year, analysts expect an EPS growth of 34.09% and a revenue growth 93.92% for NMTC